ACM
LLY icon

Alcosta Capital Management’s Eli Lilly LLY Stock Holding History

Alcosta Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.05M Sell
4,211
-256
-6% -$262K 3.42% 15
2026
Q1 		$4.11M Sell
4,467
-236
-5% -$239K 3.13% 13
2025
Q4 		$5.05M Buy
+4,703
New +$4.5M 3.18% 12
2024
Q4 		– Sell
-8,040
Closed -$7.12M – 29
2024
Q3 		$7.12M Buy
8,040
+60
+0.8% +$53.9K 4.26% 8
2024
Q2 		$7.22M Sell
7,980
-46
-0.6% -$36.8K 4.45% 8
2024
Q1 		$6.24M Sell
8,026
-29
-0.4% -$20.6K 4.19% 9
2023
Q4 		$4.7M Sell
8,055
-47
-0.6% -$27.4K 3.4% 12
2023
Q3 		$4.35M Buy
8,102
+31
+0.4% +$16K 3.63% 13
2023
Q2 		$3.79M Sell
8,071
-16
-0.2% -$6.71K 3.07% 13
2023
Q1 		$2.78M Sell
8,087
-216
-3% -$72.8K 2.66% 19
2022
Q4 		$3.04M Buy
+8,303
New +$2.94M 3.06% 15

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alcosta Capital Management's LLY Position: Q2 2026 in Review

Alcosta Capital Management reduced its Eli Lilly (LLY) stake by 5.7% in Q2 2026, selling an estimated $262K and leaving 4,211 shares worth $5.05M. The position accounts for 3.42% of the portfolio, ranked #15.

Alcosta Capital Management first reported a position in LLY in Q4 2022 and has held it in 11 quarters since. The position peaked at $7.22M in Q2 2024. 4,596 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alcosta Capital Management held 4,211 shares of Eli Lilly worth $5.05M as of Q2 2026.
  • Alcosta Capital Management sold 256 Eli Lilly shares in Q2 2026, an estimated $262K.
  • Eli Lilly made up 3.42% of Alcosta Capital Management's portfolio in Q2 2026, its #15 holding.
  • Alcosta Capital Management first reported a position in Eli Lilly in Q4 2022 and has held it in 11 quarters since.
  • Alcosta Capital Management's Eli Lilly position peaked at $7.22M in Q2 2024.
  • 4,596 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alcosta Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.